Single arm feasibility trial of a mobile application for adolescent migraine management - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Feasibility Assessment of a Mobile App for Managing Migraines in Adolescents: A Single-Arm Trial

  • By

  • Amy E Noser

  • Abigail S Robbertz

  • James Peugh

  • Marielle Kabbouche

  • Joanne Kacperski

  • Scott W Powers

  • Andrew D Hershey

  • Kevin A Hommel

  • November 5, 2024

Share

Clinical Scorecard: Feasibility Assessment of a Mobile App for Managing Migraines in Adolescents: A Single-Arm Trial

At a Glance

CategoryDetail
ConditionMigraine in adolescents
Key MechanismsBiobehavioral interventions via mobile app including relaxation training, biofeedback (heart rate variability), education, cognitive-behavioral pain management, sleep, and trigger identification
Target PopulationAdolescents aged 13–17 years with confirmed migraine diagnosis
Care SettingTertiary headache clinic and home-based mobile app use

Key Highlights

  • High feasibility with 83% recruitment and 90% completion rates among adolescents using the Easeday app.
  • Participants showed improvements in anxiety, pain catastrophizing, and functional disability with medium-to-large effect sizes.
  • User feedback highlighted benefits of relaxation and education modules but noted difficulties with biofeedback usability and diary length.

Guideline-Based Recommendations

Diagnosis

  • Confirm migraine diagnosis using International Classification of Headache Disorders Criteria (ICHD-3).

Management

  • Incorporate pharmacological therapy alongside adherence to healthy habits (sleep, hydration, diet, exercise).
  • Use biobehavioral interventions such as relaxation training, biofeedback, and cognitive-behavioral pain management.
  • Utilize mobile health platforms to deliver biobehavioral interventions to improve access and adherence.

Monitoring & Follow-up

  • Employ headache and sleep diaries to track symptoms and treatment adherence.
  • Assess functional disability, anxiety, pain catastrophizing, and quality of life measures pre- and post-intervention.

Risks

  • Consider barriers such as device compatibility and app usability issues that may impact engagement.
  • Monitor for incomplete diary data and app malfunctions that could affect treatment adherence.

Patient & Prescribing Data

Adolescents aged 13–17 years with chronic migraine or continuous headache

Engagement with a mobile app delivering relaxation and biofeedback is feasible and associated with reduced anxiety, pain catastrophizing, and functional disability; however, usability challenges may limit consistent use.

Clinical Best Practices

  • Encourage use of relaxation and breathing techniques early in headache episodes to manage stress.
  • Incorporate education modules to help patients identify migraine triggers.
  • Address usability issues in digital therapeutics to enhance adherence and satisfaction.
  • Use a combination of self-management strategies alongside pharmacological treatments for comprehensive care.
  • Plan for longer treatment durations and diverse patient samples in future research to validate efficacy.

References

Original Source(s)

Related Content